1. Circulatory microRNAs as potential biomarkers for major adverse cardiac events in patients with atrial fibrillation. (14th October 2021) Authors: Nopp, S; Van Der Bent, M.L; Koenigsbruegge, O; Wojta, J; Pabinger, I; Ay, C; Nossent, A.Y Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Interleukin levels and their potential association with venous thromboembolism and survival in cancer patients. (9th June 2014) Authors: Reitter, E-M; Ay, C; Kaider, A; Pirker, R; Zielinski, C; Zlabinger, G; Pabinger, I Journal: Clinical and experimental immunology Issue: Volume 177:Number 1(2014:Jul.) Page Start: 253 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P14.97 High risk of venous thromboembolism in patients with brain metastases from non-small cell lung cancer. (6th September 2019) Authors: Mir Seyed Nazari, P; Ay, C; Steindl, A; Gatterbauer, B; Frischer, J M; Dieckmann, K; Widhalm, G; Hainfellner, J A; Pabinger, I; Preusser, M; Berghoff, A Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 3 Page Start: iii91 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Treatment of cancer-associated venous thromboembolism in the age of direct oral anticoagulants. (27th March 2019) Authors: Ay, C; Beyer-Westendorf, J; Pabinger, I Journal: Annals of oncology Issue: Volume 30:Number 6(2019) Page Start: 897 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗